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Abstract
French law 2005-370 of April 22, 2005 (Leonetti’s law) brings
new rights to patients and clarifies medical practices regarding
end of life care. This new law prohibits unreasonable obstinacy in
investigations or therapeutics and authorizes the withholding or
withdrawal of treatments when they appear “useless,
disproportionate or having no other effect than solely the artificial
preservation of life”. Relief from pain is a fundamental right of
patients. With regard to pain control, the law also allows doctors to
dispense to patients “in an advanced or final phase of a serious
and incurable affliction” anti-pain treatments as needed, even if
these treatments, as a side effect, hasten their death. The drafting
of advance directives regarding end of life constitutes a new right
of patients. The decision to withdraw or withhold a treatment from
a patient unable to express their will has to take into account the
wishes they might have expressed through advance directives,
and/or the wishes of a trusted person or, lastly, of the family.
Before making any decision, physicians should respect a collegial
medical procedure. Euthanasia defined as the act of terminating
one’s life on a patient’s explicit request remains illegal.
Introduction
Currently, medical care at the end of life is often driven by
technology [1] and there is a widespread perception that
intensive care at the end of life may represent excessive and
inappropriate use of technology [2]. In American intensive
care units (ICUs), it has been observed that most deaths are
preceded by a decision to limit or withdraw life-sustaining
care [3]. A European study conducted in 1999 to 2000 has
shown that life support was limited in 73% of hospitalized
patients and 10% of ICU admissions, but shortening of the
death process remained rare [4].
Rationing of ICU admission according to survival benefits and
to avoid unreasonable pointless obstinacy is critical to
decrease undue ICU admissions. Allowing clear mandates
from patients about when to forgo life-sustaining therapy will
also probably greatly decrease the proportion of patients
admitted to ICU shortly before death [5]. The constantly
increasing elderly population in developed countries will
require more effective advanced care planning and
augmented specific palliative capacity to care for dying
patients [5]. Nowadays, the necessity to set limits on life
support has become commonplace [2]. Avoidance of
inappropriate care in the ICU is a major concern but remains
a difficult goal to achieve, particularly in the absence of any
consensual approach to end of life care. Fears related to
judicial rulings also have a significant impact on medical
practice [2].
In France, the LATAREA 1 survey conducted in 1997 has
shown that 50% of deaths in French ICUs were related to a
LATA (limitation ou arrêt des thérapeutiques actives) decision
[6]; of the concerned patients, 75% were unable to express
their will [6]. But before 2005 in France, the law did not allow
such decisions and practices. This established fact justifies
legal measures to frame the withholding and withdrawing of
treatment in cases where poor quality of life is expected or in
futile situations.
The case of Vincent Humbert, a young man suffering post-
traumatic locked-in syndrome [7], and public opinion con-
cerning end of life medical choices prompted a government
initiative: the French Parliamentary Mission for Information on
End-of-life Supportive Care was created in 2003. It was
made up of politicians, jurists, ethicists, clergymen, ministers,
physicians and caregivers involved in intensive care and
palliative care, and representatives of civil society. After a 9-
month inquiry, 60 statements by individuals, and a 600-page
report, the Parliamentary Commission proposed a law on
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“Patients’ rights and the end of life” [8]. In April 2005, the
French parliament unanimously passed law 2005-370
regarding end of life (the so-called Leonetti’s law) [9]. The main
items and key points of this law are discussed below (Tables 1
and 2). (Please note that the translations of Leonetti’s law
presented here do not constitute an official translation and
have not been validated by the French authorities.)
Preservation of human dignity
“The doctor safeguards the dignity of the dying and ensures
the quality of their end of life.” [9]
Despite the absence of a definition of human dignity, it is a
general consensus in the medical world that the preservation
of a patient’s dignity and choices is a goal of paramount
importance. Physicians and caregivers are, however, often
unaware of a patient’s last will and wishes regarding their end
of life [10,11] and in these circumstances care may not be
consistent with the patient’s feelings and wishes [12].
Patients who are likely to die are at particular risk of having
their dignity endangered and their will and preferences
regarding end of life disregarded. In the absence of a
patient’s will being clearly recorded, the risk of unsuitable or
blurred decisions that lengthen the duration of the dying
process is deemed to increase [13]. The preservation of
patients’ dignity is a constant concern of Leonetti’s law and
the commitment to this is repeated several times throughout it.
Avoidance of unreasonable obstinacy
Article 1: “The acts of prevention, investigation or treatment
must not be continued with unreasonable obstinacy. When
they seem useless, disproportionate or to have no other
effect than solely the artificial preservation of life, they can be
withheld or withdrawn.” [9]
Unreasonable obstinacy is the French equivalent of the
Anglo-Saxon concept of futility. It is defined as a combination
of pointlessness and disproportion in treatment given to a
patient with regard to expected benefits. Its avoidance is a
legal obligation required by Leonetti’s law and a moral duty
(the French medical deontology code, version 2006, Article
37 has integrated the law’s first article) [14]. Doctors have
then to weigh the burden and acceptability of a treatment
against expected benefits before deciding to initiate or
withhold it.
Table 1
Selected articles of Law 2005-370 of April 22, 2005 relating to Patients’ rights and to the End of life
Article 1
“The acts of prevention, investigation or treatment must not be continued with unreasonable obstinacy. When they seem useless, disproportionate
or to have no other effect than solely the artificial preservation of life, they can be withheld or withdrawn. In that case, the doctor safeguards the
dignity of the dying and ensures the quality of their life.”
Article 5
“When a person is not in a condition to express their will, treatment limitation or cessation that could endanger their life cannot be realised without
first respecting the collegial procedure defined by the code of medical ethics and without consulting the trusted person or the family or, failing this,
one of their close relations and, if appropriate, the advance directives of the person. The motivated decision to limit or discontinue treatment is
registered in the medical record.”
Article 6
“When a person in an advanced or terminal phase of a severe and incurable affliction, whatever the cause, decides to limit or to stop any treatment,
the doctor must respect their will after having informed them about the consequences of their choice. The decision of the patient is registered in
their medical record. The doctor safeguards the dignity of the dying and ensures the quality of their end of life.”
Article 7
“Every person of age can prepare advance directives in case they are one day in a condition that prevents them from expressing their will. These
advance directives indicate the wishes of the person concerning their end of life and the conditions surrounding the limitation or stopping of
treatment. They can be revoked by the person at any time.
Provided that they were established less than three years before the state of unconsciousness of the person, the doctor takes them into account
for any decision about investigation, intervention or treatment regarding them.”
Article 8
“When a person in an advanced or terminal phase of a grave and incurable affliction, whatever the cause, and in a condition that prevents them
from expressing their will, has appointed a trusted person, the opinion of this trusted person, except in cases of emergency or when it is impossible
to contact them, prevails over any other non-medical opinion, with the exception of any advance directives, in the decisions concerning
investigation, intervention or treatment made by the doctor.”
Article 9
“When a person in an advanced or terminal phase of a grave and incurable affliction, whatever the cause, and in a condition that prevents them
from expressing their will, the doctor can decide to limit or to stop a futile or disproportionate treatment that has no other effect than solely the
artificial continuation of the life of this person, having respected the collegial procedure defined by the code of medical ethics and consulted the
trusted person, the family or, failing this, one of his close relations and, if appropriate, the advance directives of the person. The doctor’s motivated
decision is registered in the medical record. The doctor safeguards the dignity of the dying patient and ensures the quality of their end of life.”Respect of patients’ choices
Article 6: “When a person in an advanced or terminal phase of
a severe and incurable affliction, whatever the cause, decides
to limit or to stop any treatment, the doctor must respect their
will after having informed them about the consequences of
their choice. The decision of the patient is registered in their
medical record. The doctor safeguards the dignity of the dying
and ensures the quality of their end of life.” [9]
Advance directives
Article 7: “Every person of age can prepare advance
directives in case they are one day in a condition that
prevents them from expressing their will. These advance
directives indicate the wishes of the person concerning their
end of life and the conditions surrounding the limitation or
stopping of treatment. They can be revoked by the person at
any time.
Provided that they were established less than three years
before the state of unconsciousness of the person, the
doctor takes them into account for any decision about
investigation, intervention or treatment regarding them.” [9]
Advance directives are not legally binding and do not relieve
doctors of their liabilities. This European attitude of a doctor’s
liability despite their patient’s wishes is opposite to the
American attitude where a patient’s autonomy is the main
criterion for decision making [15].
The mandated trusted person
“Every person of age can appoint a trusted person, who can
be a parent, a close relative or the family doctor, who will be
consulted in case the person is unable to express his/her
will and to receive the information necessary to achieve this.
This appointment is made in writing. It can be revoked by the
person at any time. If the patient wants, the trusted person
can accompany them and attend medical consultations to
help them in their decision making.
During any hospitalization in a health establishment, it is
suggested to the patient that they appoint a trusted person
according to the conditions specified in the previous para-
graph. This appointment is valid for the hospitalization time,
unless the patient arranges it otherwise.”
“The arrangements of the present article do not apply when
a measure of guardianship (protection) is ordered. However,
the judge supervising a guardianship case can, when a
trusted person has been previously appointed by the patient,
either confirm the appointment of the previously indicated
trusted person, or revoke their appointment.” [16]
Article 8: “When a person in an advanced or terminal phase
of a grave and incurable affliction, whatever the cause, and
in a condition that prevents them from expressing their will,
has appointed a trusted person, the opinion of this trusted
person, except in cases of emergency or when it is
impossible to contact them, prevails over any other non-
medical opinion, with the exception of any advance direc-
tives, in the decisions concerning investigation, intervention
or treatment made by the doctor.” [9]
According to Leonetti’s law, the trusted person is not a
surrogate decision-maker because the burden of medical
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Table 2
Decree 2006-120 of February 6th, 2006 concerning the statutory collegial procedure 2005-370 of April 22nd, 2005 relative to the
rights of patients and at the end of life
Article 1: the article R. 4127-37 of the Code of public health is replaced by the following amendments:
Article R. 4127-37, I: In all circumstances, the doctor must endeavour to alleviate the patient’s suffering by means adapted to his/her state of health
and assist him/her morally. He/she must refrain from any unreasonable obstinacy in his/her investigations or therapies and may stop undertaking or
pursuing treatments which appear pointless, disproportionate or which have no other aim or effect than the artificial maintenance of life.
Article R. 4127-37, II: When the patient is unable to express his/her will, the doctor shall not decide to limit or stop ongoing treatments without
having previously implemented a collegial procedure in the following manner:
“The decision shall be reached by the doctor treating the patient, after consultation with the care team if there is one and in concordance with
the opinion of at least one other doctor, called in as a consultant. The motives for the opinion shall be made explicit. There must be no
hierarchical tie between the doctor treating the patient and the consultant. The opinion of a second consultant shall be requested by these
doctors if this is considered useful by one of them.”
“The decision shall take into account: the desires which the patient may have expressed previously, in particular in his/her advance directives, if
he/she has written any; the opinion of the trusted person he/she may have appointed; as well as that of the family or, failing that, of one of
his/her close relations.”
“When the decision concerns a minor or a person of full age under protective supervision, the doctor shall also ask for, depending on cases,
the opinion of persons having parental authority or of the guardian, except in situations where emergency might make this consultation
impossible.”
“The motives for the decision shall be made explicit. The views provided, the nature and meaning of the consultations that took place in the
care team, and the reasons for the decision shall be noted in the patient’s record.”decisions is thought to remain with the physician in charge of
the patient and not with the relatives. The trusted person is
rather a witness who reports a patient’s point of view and
wishes regarding their end of life if the patient is unable to do
so. The law specifies that the opinion of the trusted person
prevails over any other non-medical opinion, unless advance
directives have been drawn up by the patient.
Any decision of treatment cessation must be accompanied by
appropriate palliative care, especially if the assessment of
suffering is rendered difficult by the neurological status of the
patient.
The law acknowledges the validity of the will of conscious
and capable patients to refuse life-saving treatment. A
patient’s decision must be constant and repeated after “a
reasonable time lapse” to enable the medical team to be
confident in it. In this case, treatment includes mechanical
ventilation, dialysis and artificial nutrition. For this reason,
emergency situations are outside the scope of the law. In
every case of treatment cessation, care must be given to
ascertain that the patient’s suffering is appropriately treated.
Improvement of communication and
consensuality
Article 5: “When a person is not in a condition to express his
will, treatment limitation or cessation that could endanger
their life cannot be realised without first respecting the
collegial procedure defined by the code of medical ethics
and without consulting the trusted person or the family or,
failing this, one of their close relations and, if appropriate, the
advance directives of the person. The motivated decision to
limit or discontinue treatment is registered in the medical
record.” [9]
Article 9: “When a person in an advanced or terminal phase
of a grave and incurable affliction, whatever the cause, and
in a condition that prevents them from expressing their will,
the doctor can decide to limit or to stop a futile or
disproportionate treatment that has no other effect than
solely the artificial continuation of the life of this person,
having respected the collegial procedure defined by the
code of medical ethics and consulted the trusted person, the
family or, failing this, one of his close relations and, if
appropriate, the advance directives of the person. The
doctor’s motivated decision is registered in the medical
record. The doctor safeguards the dignity of the dying patient
and ensures the quality of their end of life.” [9]
Prior studies have shown a high level of anxiety and
depression among family members of critically ill patients
[17], a significant burden of symptoms of post-traumatic
stress disorder among family members [18], and a significant
amount of conflict within the ICU team or between the team
and family members around issues of withdrawing life
support [19,20]. High degrees of conflict or unresolved
conflict may severely lower end of life care quality and even
lead to legal issues.
A major means to gain acceptance of strategies to limit
treatment is to improve communication within the clinical
team and between the team, the patient if possible, and their
family [21,22]. Optimal quality of inter-individual communi-
cation is critical not only during the process of decision-
making to withdraw life-sustaining therapies, but also after the
decision is made, to provide the best help to relatives [23].
Several topics should be covered with family members,
including explanations of how the patient’s comfort will be
ensured, the patient’s probable length of survival, the
continuation of some care by the clinical team, and family or
patient preferences concerning spiritual needs [23,24].
Collegial decisions
“The decision shall be reached by the doctor treating the
patient, after consultation with the care team if there is one
and in concordance with the opinion of at least one other
doctor, called in as a consultant. The motives for the opinion
shall be made explicit. There must be no hierarchical tie
between the doctor treating the patient and the consultant.
The opinion of a second consultant shall be requested by
these doctors if this is considered useful by one of them.”
[25]
Goals of paramount importance are to prevent the possibility
of a self-fulfilling prophecy regarding a patient’s prognosis, to
prevent emotional judgements about the foreseeable
disability of a patient, and to prevent decisions about treat-
ment limitation being the choice of just a single physician. It is
also of paramount importance to rightly differentiate
physician-perceived disability from that experienced by the
patient himself. The European guide to medical ethics,
decreed in 1987, states in its fourth article: “The physician
cannot substitute his own conception of the quality of life for
that of his patient.” [26]
The collegial procedure indeed involves an independent
corroboration of the diagnosis and prognosis. The essential
purposes are threefold: to avoid the possibility of an auto-
confirmed prediction regarding the prognosis of the patient
(self-fulfilling prophecy); to prevent a doctor from making
solely emotional judgements about the foreseeable disability
of a patient; and to give the patient and their family a
guarantee that at least two independent doctors have judged
the treatment as unreasonable. Decisions made outside a
collective framework could result in undue limitation of
treatment. The care-giving team must be consulted during the
decision-making process and informed of the final decision.
If a consensus between the medical/care-giving team, the
family and/or the trusted person is not reached, the treatment
limitation procedure should be postponed or aborted,
although this is not a legal obligation. Despite the collegial
Critical Care    Vol 13 No 1 Baumann et al.
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remains liable for the final decision.
Limiting care not related to providing comfort
The spirit of the law is to allow removal of treatments that are
no longer wanted by the patient or reasonably indicated and
that do not provide comfort to them. If the patient is
unconscious, whether they are at the end of their life or not,
the procedure of limitation or arrest of treatment has to satisfy
three requirements: respect of the individual will of the
patient; dialogue and medical collegiality; and traceability of
all decisions in the medical record. The decision to withdraw
life support as well as the rationale for this decision should be
documented in the medical record, as well as the reasons for
increasing sedation or analgesia if needed. Adequate
analgesia and sedation should remain a priority in this setting.
Double effect concept
Acknowledging the fact that end of life care may sometimes
include a grey area between treatments administered to
relieve pain and suffering and those intended to shorten the
dying process, possibly entailing legal issues [27], French
legislators have allowed doctors to increase the dose of
sedatives and/or analgesic drugs to relieve patient suffering
even if doing so might shorten a patient’s life, provided that
the patient or the family are informed and that shortening of
the patient’s life is not the goal but only a possible side effect
of the therapeutics. This concept has already been stated in
other countries, especially the UK.
Development of palliative care
Article D. 311-38: “When a general care project is planned
for the application of the institution’s or service’s project as
mentioned in Article L. 311-8, it shall define all measures
ensuring the palliative care required by the state of health of
patients, including specific personnel training plans.” [28]
Leonetti’s law seeks to develop a palliative care culture by
concurrently detailing the legal requirements of doctors and
introducing an obligation to increase palliative care capacity.
This obligation to acquire the capacity to provide palliative
care has been extended to the medico-social establishments
providing accommodation for the elderly, and to the
healthcare establishments providing long-term care [9].
Public funds have been allocated to support these new
obligations.
Discussion
Attitudes towards end of life care are very diverse among the
countries of the European Community [29,30]: the
Netherlands, Belgium and Switzerland [31] have legalized
euthanasia; the UK has endorsed a patient’s or their family’s
autonomy, similar to in the US but without any clear legal
position on a doctor’s rights when facing an incompetent
patient [32]; and Germany has acknowledged advance
directives and allows passive and indirect assistance to die
[33,34]. The European tradition clearly keeps doctors liable
for final decisions regarding end of life care.
In France, Leonetti’s law is aimed at improving end of life care
in several ways: by reducing the “prolongation of dying”; by
legalising decisions to forego life-sustaining treatments; by
promoting strategies to improve patient comfort and palliative
care to alleviate patient suffering; by decreasing psycho-
logical distress for family members and reducing conflicts
among ICU team members and between team and family
members; and by reducing the number of concealed
euthanasia procedures and subsequent feelings of guilt.
Many people involved in end of life situations claim that the
approach used in hospitals has not really changed since the
introduction of this law, and there is, therefore, an urgent
need to evaluate the impact of the law on medical practice,
particularly with regard to incompetent or unconscious
patients (that is, in the context of the collegial decision-
making process and advance directives). At the initiative of
the French parliament, this evaluation is now in progress.
Besides this, a survey initiated in 2005 throughout the whole
country pointed out the fact that palliative care in France is
not developed enough to allow real application of Leonetti’s
law [35].
In France euthanasia remains illegal, although particular cases
periodically make the front pages of publications in support of
demands for an extension of Leonetti’s law towards the
legalisation of euthanasia, and public debate is ongoing.
Aspects of modern end of life care should include patient
involvement and appropriateness of care. Towards this, we first
need a change in medical culture that Leonetti’s law enables.
Conclusion
Leonetti’s law institutes a method of care that involves: the
constant seeking for consensus; the purposeful choice of
options; condemnation of unreasonable therapeutic obsti-
nacy and the right of patients to object to it. It also affirms
principles, including: respect of patients’ will; the need to
confer with patients, and their relatives and caregivers;
medical collegiality; and the expansion of palliative care [36].
In passing this law, the French Parliament pursued
essentially two objectives: to acknowledge a patient’s right
to oppose unreasonable obstinacy; and to delineate good
medical practices, both when a patient is conscious or
unconscious, and whether or not they are at the end of life
[36]. The main change it introduced is the possibility for
physicians in France to withhold or even withdraw life
support for unconscious patients.
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